Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000074

Options or other derivatives

  • Chief Executive Officer acquired 629,156 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Goff Brian · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-08-08 Grant or award : show line 1 in the form Stock option (right to buy) +561,083 561,083 D
2022-08-08 Grant or award : show line 2 in the form Restricted stock units +68,073 68,073 D
Loading xslF345X03/wf-form4_166007821499099.xml…